Grace Choong

New #ASCO24 research showed that omission of adjuvant endocrine therapy in patients with ER-low, early-stage #BreastCancer is associated with a 25% increased risk of death compared with receipt of adjuvant ET: brnw.ch/21wKkAS #ASCODailyNews #BCSM @mpgoetz @GraceChoongMD

@mpgoetz Thank you to my mentors @mpgoetz and @DrJudyBoughey on their guidance for this presentation! The omission of ET in ER-low breast cancer is associated with 25% increased risk of death. More studies are needed to determine the subgroup most likely to benefit from ET.

What is the impact of endocrine therapy omission in ER low (IHC 1-10%) breast cancer? Dr. Grace Choong presents data at ASCO 2024 regarding the detrimental impact of ET omission in this group of pts with tumors traditionally characterized as biologically similar to TNBC

Introducing our incoming Chief Fellows - @RichGodby and Caleb Smith!

We are so excited for the @MayoHemeOnc 5th Annual Career Development Retreat and have a phenomenal line up of topics and guest speakers! #MedEd #AIinMedicine #YoungInvestigator #FDAoncology